Biomea Fusion Company
Biomea Fusion is a precision oncology company developing novel small molecules that target aggressive forms of cancer.
Last Funding Type:
Series A
Funding Status:
IPO
Headquarters:
Redwood City, California, United States
Founded Date:
2017-01-01
Last Funding Date:
2021-01-06
Total Funding:
56000000.0
Technology:
Biotechnology, Life Science, Therapeutics
Employee Number:
11-50
Estimated Revenue:
$10M to $50M
Investors Number:
8.0
Industry:
Early Drug Development